Antimicrobial Resistance and Infection Control
Antimicrobial resistance (AMR) has emerged as one of the most pressing global health challenges of the twenty-first century, threatening the effectiveness of antibiotics, antivirals, antifungals, and antiparasitic medications that have transformed modern medicine. The increasing prevalence of drug-resistant pathogens compromises the treatment of infectious diseases, prolongs hospital stays, increases healthcare costs, and contributes significantly to morbidity and mortality worldwide. This session will explore the scientific, clinical, and public health dimensions of antimicrobial resistance while highlighting innovative approaches to infection prevention and control. Participants will examine the mechanisms underlying resistance development, including genetic mutations, horizontal gene transfer, selective antimicrobial pressure, and environmental influences that facilitate the emergence and spread of resistant microorganisms. Discussions will focus on major resistant pathogens affecting healthcare and community settings, surveillance strategies for monitoring antimicrobial resistance trends, and the implementation of antimicrobial stewardship programs aimed at optimizing medication use and preserving treatment effectiveness. The session will also address infection prevention measures, including healthcare-associated infection control practices, hygiene interventions, environmental decontamination, vaccination strategies, and public awareness initiatives. Researchers and healthcare professionals will present findings related to novel antimicrobial agents, alternative therapeutic approaches, rapid diagnostic technologies, and emerging tools for resistance detection and management. Special emphasis will be placed on multidisciplinary collaboration among clinicians, microbiologists, pharmacists, infection control practitioners, policymakers, and public health agencies to combat resistance at local, national, and global levels. By fostering knowledge exchange and scientific dialogue, this session aims to support sustainable solutions that strengthen infection control practices and address the growing threat of antimicrobial resistance.